Steen Werner Hansen

University of Alabama at Birmingham — United States

Medicine · Health Sciences

23h-index4.3kcitations63works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Testicular diseases and treatments(14), Cancer Treatment and Pharmacology(10), Sperm and Testicular Function(6), Lung Cancer Research Studies(6), Chemotherapy-induced organ toxicity mitigation(6)

Publications63 total

Leveraging probiotic biogeography to prevent dysbiosis in the neonatal intestine 4705
The Journal of Immunology·2025Open Access
Probiotic biogeography and sepsis prevention in the neonatal intestine
2025Open Access
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
Journal of Clinical Oncology·2023· 39 citedOpen Access
Real-world evidence to guide healthcare policies in oncology
Oncotarget·2019· 12 citedOpen Access
[Antibiotic stewardship has been established at Herlev Hospital].
PubMed·2014
The clinical introduction of high sensitivity cardiac troponin will redefine patient categories in acute coronary syndromes and increase prognostic information
European Heart Journal·2013
USEFULNESS OF CREATINE-KINASE MYOCARDIAL BAND IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION AFTER THE ADVENT OF HIGH-SENSITIVITY CARDIAC TROPONINS
Journal of the American College of Cardiology·2013· 1 cited
Urimeligt og videnskabeligt ukorrekt angreb mod Region Hovedstaden
Ugeskrift for Læger·2010
The European Medicines Agency (EMEA) guideline on oncology drug development
Journal of Clinical Oncology·2007· 5 cited
Rapid subcutaneous IgG replacement therapy in children and adults 20 years o clinical experience
Inmunología·2005
Severe neurotoxicity caused by gemcitabine treatment
Acta Oncologica·2004· 22 citedOpen Access
[Cancer treatment in Denmark--an international standard?].
PubMed·2004
[Quality assurance is gaining ground. The Danish Society of Quality in Health Care].
PubMed·2004
386 High-dose chemotherapy with stem cell support in high-risk primary breast cancer. An analysis of the effect on overall survival the Danish experience from a comparison study
European Journal of Cancer Supplements·2003
[The cancer plan. Political will--professional formation].
PubMed·2002· 1 cited
Effect of Graded Testicular Doses of Radiotherapy in Patients Treated for Carcinoma-In-Situ in the Testis
Journal of Clinical Oncology·2002· 82 cited
Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma
Seminars in Oncology·2002· 34 cited
Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study
Acta Oncologica·2002· 6 citedOpen Access
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
Journal of Clinical Oncology·2000· 2.3k citedOpen Access
The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer
Annals of Oncology·1999· 51 cited
page 1 of 4Next →

Frequent Co-authors

Mikael Rørth(11), Gedske Daugaard(9), J Pedersen-Bjergaard(5), Preben Philip(5), Hans von der Maase(4), Severin Olesen Larsen(4), Malgorzata Tuxen(4), Peter Meidahl Petersen(4), Aleksander Giwercman(4), Niels Nygaard Rossing(4), Hans Erik Johnsen(4), Heine H. Hansen(3), S. Groth(3), Peter G. Sørensen(3), J.T. Roberts(2), Luigi Dogliotti(2), T. Oliver(2), Malcolm J. Moore(2), I. Bodrogi(2), Peter Albers(2)